arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Flushing

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with Flushing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrne, B; Clive, S; Jodrell, DI; MacLellan, A; Robson, L; Smyth, JF; Webb, DJ; Young, A	1

Trials

1 trial(s) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Flushing

Article	Year
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Brachial Artery; Bradykinin; Dose-Response Relationship, Drug; Female; Flushing; Forearm; Humans; Infusion Pumps; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuropeptides; Oligopeptides; Regional Blood Flow; Substance P; Treatment Outcome; Vasodilator Agents	2001

Article

Year

Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

Topics: Adult; Aged; Antineoplastic Agents; Brachial Artery; Bradykinin; Dose-Response Relationship, Drug; Female; Flushing; Forearm; Humans; Infusion Pumps; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuropeptides; Oligopeptides; Regional Blood Flow; Substance P; Treatment Outcome; Vasodilator Agents

2001